Skip to main content

Table 1 Sociodemographic and lifestyle factors associated with colposcopy attendance among all women referred

From: Colposcopy non-attendance following an abnormal cervical cancer screening result: a prospective population-based cohort study

 

Overall (n = 308)

Logistic regression models

 

Non-attendee (n = 89)

Attendee (n = 219)

Univariable

Multivariablea

 

n (row %)

n (row %)

OR

95% CI*

aOR

95% CI**

Age group

      

 30–39 years

28 (31.46%)

61 (68.54%)

Ref

 

Ref

 

 40–49 years

29 (25.44%)

85 (74.56%)

1.35

0.73, 2.49

1.55

1.02, 4.96

 50–59 years

22 (30.14%)

51 (69.86%)

1.06

0.54, 2.09

1.18

0.63, 3.40

 60+ years

10 (31.25%)

22 (68.75%)

1.01

0.43, 2.49

1.07

0.32, 3.72

 Missing

0

0

    

Nationality

      

 Non-German

13 (40.62%)

19 (59.38%)

Ref

 

Ref

 

 German

76 (27.54%)

200 (72.46%)

1.80

0.83, 3.80

1.58

0.96, 5.97

 Missing

0

0

    

Study region

      

 Mainz-Bingen (rural)

41 (24.12%)

129 (75.88%)

Ref

 

Ref

 

 Mainz (urban)

48 (34.78%)

90 (65.22%)

0.60

0.36, 0.98

0.63

0.30, 1.00

 Missing

0

0

    

Education

      

 Upper secondary or further1

36 (30.77%)

81 (69.23%)

Ref

 

Ref

 

 Lower secondary2

53 (27.75%)

138 (72.25%)

1.16

0.70, 1.91

1.01

0.75, 2.15

 Missing

0

0

    

Employment

      

 Employed

60 (27.91%)

155 (72.09%)

Ref

 

Ref

 

 Not employed3

22 (32.35%)

46 (67.65%)

0.81

0.45, 1.48

0.97

0.50, 1.83

 Missing

7

18

    

Net household income

      

 ≤ 1500€/month

9 (13.43%)

58 (86.57%)

Ref

 

Ref

 

 > 1500€/month

58 (31.69%)

125 (68.31%)

0.33

0.15, 0.69

0.33

0.11, 0.92

 Missing

22

36

    

Marital status

      

 Married, divorced, widowed

69 (27.49%)

182 (72.51%)

Ref

 

Ref

 

 Single

17 (32.08%)

36 (67.92%)

0.80

0.43, 1.55

0.72

0.22, 1.12

 Missing

3

1

    

Parity

      

 0–2

64 (26.45%)

178 (73.55%)

Ref

 

Ref

 

 ≥ 3

18 (46.15%)

21 (53.85%)

0.42

0.21, 0.84

0.32

0.10, 0.86

 Missing

7

20

    

Smoking status

      

 Never

34 (25.76%)

98 (74.24%)

Ref

 

Ref

 

 Ever

54 (31.03%)

120 (68.97%)

0.77

0.46, 1.27

0.76

0.32, 1.01

 Missing

1

1

    

Oral contraceptive use

      

 Never

17 (29.82%)

40 (70.18%)

Ref

 

Ref

 

 Ever

72 (28.80%)

178 (71.20%)

1.05

0.55, 1.95

0.90

0.28, 1.28

 Missing

0

1

    

HRT

      

 Never

74 (28.24%)

188 (71.76%)

Ref

 

Ref

 

 Ever

12 (31.58%)

26 (68.42%)

0.85

0.42, 1.83

0.96

0.29, 1.55

 Missing

3

5

    

Health insurance

      

 Statutory

54 (28.12%)

138 (71.88%)

Ref

 

Ref

 

 Private

9 (30.00%)

21 (70.00%)

0.91

0.40, 2.21

1.14

0.70, 4.62

 Missing

26

60

    

Screening frequency

      

 Regular4

70 (27.24%)

187 (72.76%)

Ref

 

Ref

 

 Irregular or never5

19 (40.43%)

28 (59.57%)

0.55

0.29, 1.06

0.82

0.30, 1.13

 Missing

0

4

    

Screening result

      

 ASC-US+ only

40 (47.62%)

44 (52.38%)

Ref

 

Ref

 

 hrHPV+ only

40 (22.47%)

138 (77.53%)

3.25b

1.91, 5.55

3.04b

1.49, 7.22

 Both positive

9 (19.57%)

37 (80.43%)

    
  1. OR: odds ratio; CI: confidence interval; aOR: adjusted odds ratio; Ref: reference level; HRT: hormone replacement therapy; ASC-US+: Atypical squamous cells of undetermined significance or worse; hrHPV+: high-risk Human Papillomavirus positive; both positive: ASC-US+ and hrHPV positive
  2. 1 at least 12 years education
  3. 2 ≤ 10 years
  4. 3 includes other employment status such as parental leave, sick leave
  5. 4 every 1–2 years
  6. 5 every 3 years or less, irregular screening, rarely and no previous screening attendance
  7. a Adjusted for all covariates in the model
  8. b dichotomised to include hrHPV only and both co-test positive results (hrHPV and ASC-US+)
  9. * Likelihood ratio
  10. ** Bootstrap resampled confidence intervals (n = 500)
Back to article page

BMC Women's Health

ISSN: 1472-6874

Contact us